Hui-Guo Liu Selected Research

Respiratory Insufficiency (Respiratory Failure)

5/2020

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Guo Liu Research Topics

Disease

16	Hypoxia (Hypoxemia) 09/2022 - 12/2008
7	Obstructive Sleep Apnea 01/2022 - 12/2008
4	Hypertension (High Blood Pressure) 04/2013 - 12/2008
3	Cardiomegaly (Heart Hypertrophy) 06/2018 - 09/2015
2	Hypertrophy 06/2018 - 09/2015
2	Sleep Apnea Syndromes (Sleep Apnea) 08/2015 - 11/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Diastolic Heart Failure 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Liver Neoplasms (Liver Cancer) 08/2022
1	Liver Diseases (Liver Disease) 08/2022
1	Optic Nerve Diseases (Optic Neuropathy) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 06/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2020
1	Shock 06/2020
1	Disseminated Intravascular Coagulation 06/2020
1	COVID-19 05/2020
1	Pneumonia (Pneumonitis) 05/2020
1	Respiratory Insufficiency (Respiratory Failure) 05/2020
1	Critical Illness (Critically Ill) 05/2020
1	Disease Progression 05/2020
1	Fatty Liver 09/2019
1	Obesity 09/2019
1	Ventricular Remodeling 08/2017
1	Inflammation (Inflammations) 08/2017
1	Cardiomyopathies (Cardiomyopathy) 08/2017
1	Cognitive Dysfunction 04/2016
1	Nervous System Diseases (Neurological Disorders) 04/2016
1	Neuroinflammatory Diseases 08/2015
1	Body Weight (Weight, Body) 01/2013
1	Erectile Dysfunction 11/2012

Drug/Important Bio-Agent (IBA)

6	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013 - 12/2008
4	Messenger RNA (mRNA)IBA 01/2013 - 06/2009
3	MelatoninIBA 09/2022 - 09/2015
3	NADP (NADPH)IBA 04/2013 - 06/2009
2	SirtuinsIBA 09/2022 - 09/2019
2	Sirolimus (Rapamycin)FDA Link 09/2019 - 01/2016
2	Angiotensin IIIBA 09/2017 - 01/2013
2	Protein Kinases (Protein Kinase)IBA 01/2016 - 09/2015
2	acetovanillone (apocynin)IBA 04/2013 - 12/2008
2	Oxidoreductases (Dehydrogenase)IBA 02/2010 - 06/2009
1	fibrin fragment D (D-dimer)IBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	NitrogenIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	6,7-dihydroxyflavoneIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 06/2020
1	C-Reactive ProteinIBA 05/2020
1	AlbuminsIBA 05/2020
1	Immunoglobulin G (IgG)IBA 05/2020
1	Nucleic AcidsIBA 05/2020
1	Transaminases (Aminotransferases)IBA 09/2019
1	Sirtuin 1IBA 09/2019
1	3-methyladenineIBA 09/2019
1	sirtinolIBA 09/2019
1	SRT1720IBA 09/2019
1	Atorvastatin (Lipitor)FDA Link 06/2018
1	MicroRNAs (MicroRNA)IBA 06/2018
1	Type C PhospholipasesIBA 09/2017
1	Phospholipases (Phospholipase)IBA 09/2017
1	Losartan (Cozaar)FDA LinkGeneric 09/2017
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 09/2017
1	rho-Associated KinasesIBA 08/2017
1	fasudil (AT 877)IBA 08/2017
1	NF-kappa B (NF-kB)IBA 08/2017
1	Glycogen Synthase (Synthase I)IBA 04/2016
1	CateninsIBA 04/2016
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	Adenosine Monophosphate (AMP)IBA 09/2015
1	Purinergic P2X7 ReceptorsIBA 08/2015
1	Vasoconstrictor AgentsIBA 04/2013
1	Endothelin-1 (Endothelin 1)IBA 04/2013
1	SaltsIBA 01/2013
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2013
1	Myosin-Light-Chain KinaseIBA 01/2013
1	Contractile ProteinsIBA 01/2013
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2013
1	Myosin-Light-Chain PhosphataseIBA 01/2013
1	ThioredoxinsIBA 09/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2009
1	Superoxide DismutaseIBA 06/2009

Therapy/Procedure

1	Therapeutics 01/2023
1	Continuous Positive Airway Pressure 09/2015